MedTrace Logo

Study of Triostat in Infants During Heart Surgery

NCT00027417 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 195

Last updated 2013-08-05

No results posted yet for this study

Summary

This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery.

Conditions

  • Heart Defects, Congenital

Interventions

DRUG

Liothyronine sodium/triiodothyronine

PROCEDURE

Cardiopulmonary bypass and cardiac surgery

Sponsors & Collaborators

  • Michael Portman

    lead OTHER

Principal Investigators

  • Michael Portman, MD · Seattle Childrens Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-04-30
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00027417 on ClinicalTrials.gov